Clinical Neuroimmunology and Brain Tumors Study Section [CNBT]

[CNBT Membership Roster] [CNBT Meeting Rosters]


The Clinical Neuroimmunology and Brain Tumors [CNBT] Study Section reviews applications involving central and nervous system disorders where the focus is on immune response, inflammation and infections. The experimental systems include in vitro, animal models of human neuromuscular and neurodegenerative disorders as well as patient-oriented research. Specific areas covered by CNBT:

  • The relevant diseases are multiple sclerosis, myasthenia gravis, inflammatory neuropathies and myopathies, infectious diseases of the nervous system, prion disease and nervous system tumors.
  • Immunological processes in neural disease or injury: Cellular and humoral responses, innate immunity, inflammation, autoimmunity, immunotherapy, neuroimmune modulation, and cytokines/chemokines.
  • Demyelination, neuroinflammation in Alzheimer’s disease and Parkinson’s disease; reactive microglia, astrocytes, macrophages, axonal damage, regeneration, and myelination/remyelination.
  • Infectious diseases of nervous system: The parasitic, fungal, bacterial, and viral agents (excluding HIV) as well as prions causing prominent neurological symptoms; viral neurotropism/invasion, uptake, spread and characterization of infectious prions.
  • The role of blood brain barrier in inflammation, migration of leukocytes and trafficking in brain, viral gene therapy, cell transplantation, biomarkers and immune cell mediated vascular permeability.  
  • Central nervous system tumors (emphasis on CNS functional consequences): Diagnosis, mechanism, and treatment of glioblastomas, medulloblastomas, neuroblastomas and gliomas; tumorigenesis, migration, immune response, gene therapy, invasion, and angiogenesis. 
     

Study sections with most closely related areas of similar science listed in rank order are:

Hypersensitivity, Autoimmune, and Immune-mediated Diseases [HAI]
Cellular and Molecular Biology of Glia [CMBG]
Cell Death in Neurodegeneration [CDIN]
Cancer Immunopathology and Immunotherapy [CII]
Virology A Study Section [VIRA]
Virology B Study Section [VIRB]



Home | Contact CSR | Staff Directory | Site Map | FOIA | Disclaimer & Privacy Statements | Accessibility Statement
Last updated: November 24, 2008

National Institutes of Health National Institutes of Health   Department of Health and Human Services Department of Health and Human Services USA.gov Government Made Easy